Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hanyin Cheng
Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor Prognosis
PLoS ONE
Multidisciplinary
Related publications
Downregulation of Circulating Exosomal miR-638 Predicts Poor Prognosis in Colon Cancer Patients
Oncotarget
Oncology
Circulating miR-150 in CSF Is a Novel Candidate Biomarker for Multiple Sclerosis
Neurology: Neuroimmunology and NeuroInflammation
Neurology
Early Postoperative Circulating miR-483-5p Is a Prognosis Marker for Adrenocortical Cancer
Cancers
Cancer Research
Oncology
Increased Circulating Plasma Cells Detected by Flow Cytometry Predicts Poor Prognosis in Patients With Plasma Cell Myeloma
Cytometry Part B - Clinical Cytometry
Forensic Medicine
Pathology
Histology
Cell Biology
SSH1 Expression Is Associated With Gastric Cancer Progression and Predicts a Poor Prognosis
BMC Gastroenterology
Medicine
Gastroenterology
Circulating miR-200c and miR-141 and Outcomes in Patients With Breast Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
KPNA2 Is a Potential Diagnostic Serum Biomarker for Epithelial Ovarian Cancer and Correlates With Poor Prognosis
Tumor Biology
Medicine
Cancer Research
Plasma Serotonin Level Is a Predictor for Recurrence and Poor Prognosis in Colorectal Cancer Patients
Journal of Clinical Laboratory Analysis
Allergy
Immunology
Biochemistry
Public Health
Medical Laboratory Technology
Clinical Biochemistry
Hematology
Microbiology
Environmental
Occupational Health
Identification of a Novel lncRNA GABPB1‑IT1 That Is Downregulated and Predicts a Poor Prognosis in Non‑small Cell Lung Cancer
Oncology Letters
Cancer Research
Oncology